Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia.
Clin Microbiol Infect. 2011 Dec 28;
Authors: Teh B, Grayson ML, Johnson PD, Charles PG
Abstract
Clin Microbiol Infect ABSTRACT: We assessed the comparative efficacy of empirical therapy with beta-lactam plus macrolide vs. beta-lactam plus doxycycline for the treatment of community-acquired pneumonia (CAP) among patients in the Australian Community-Acquired Pneumonia Study. Both regimens demonstrated similar outcomes against CAP due to either 'atypical' (Chlamydophila, Legionella or Mycoplasma spp.) or typical bacterial pathogens.
PMID: 22284533 [PubMed - as supplied by publisher]